QCLS
NASDAQ · Pharmaceuticals
Q/C Technologies Inc
$0.78
+0.02 (+2.80%)
Open$0.74
Previous Close$0.76
Day High$0.81
Day Low$0.70
52W High$8.94
52W Low$0.42
Volume—
Avg Volume26.24M
Market Cap3.61M
P/E Ratio—
EPS$-3.83
SectorPharmaceuticals
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 6.12M | 5.83M | 5.05M |
| Net Income | 729.3K | 769.8K | 662.9K |
| Profit Margin | 11.9% | 13.2% | 13.1% |
| EBITDA | 1.12M | 1.08M | 875.0K |
| Free Cash Flow | 457.4K | 470.8K | 287.5K |
| Rev Growth | +22.0% | +12.4% | +6.3% |
| Debt/Equity | 0.30 | 0.26 | 0.28 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,164.89 | +1.04% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.47 | -0.19% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $149.50 | +1.79% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.74 | +0.29% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.62 | -0.70% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.33 | -0.10% | 11.5 | 30.15B |